Real-world results vary, and individual response depends on metabolic profile, dose tolerance, and the lifestyle structure built around the medication
Repurposing GLP-1 receptor agonists and novel dual/triple GLP-1, GIP, and glucagon agonists represent promising therapeutic strategies that have shown to be effective in targeting inflammation, tau phosphorylation, synaptic dysfunction, insulin resistance, and oxidative stress
It is short-acting, which is why it must be dosed at every meal
The cost calculator estimates expense over protocol duration, helping plan purchases and identify the most cost-effective approaches to achieving weight loss goals
Eligibility depends on the authorised indication, BMI, weight-related health conditions, medical history, current medicines and an individual clinical assessment
Retatrutide For weight loss and metabolic, cardiometabolic, and liver benefits